chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Info has been received from a health professional concerning a 9 year old white male, with no medical history and no allergies, who on 11/27/96, was vaccinated with a 1st dose of varicella virus vaccine live. There was no concomitant medications. It was reported that the pt presented to the office on 4/9/05, with approximately, 30-50 chickenpox lesions. It was noted that there was no treatment. The pt's status was reported as recovering. There were no lab or diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up info from a health professional indicated that on 4/9/05, the pt experienced a breakthrough varicella rash with 30-40 lesions. It was reported that the pt recovered. Additional info is not expected.
approx 15 mos p/ vax pt exp less than 50 papules resembling a mild chickenpox rash.
Tdap was ordered, but Dtap was given.  No adverse reactions noted, parent of patient notified.
Patient was administered ZOSTAVAX 12/16/2008 then SHINGRIX 10/04/2018 and the second dose on 12/29/2018 - Patinet was diagnosed with shingles on 02/01/2019.
The morning after receiving vacc. she reports feeling "achy, lousy and headachy" - which resolved later in the day. At the end of the day she noticed a bright red, itchy rash on left arm. Comes to office on day 3. Treatment: Antibiotic cephalexin 500mg 1 cap. every 12 hrs x 5days, cool compresses. Watch for worsening s/s.
After vax, pt. had erythematous localized rxn. Tx'd w/Benadryl & told mom to apply warm compress. ON 11/19, pt. still has erythematous, edematous area, approx. 2cmx1cm, area at inject. site. Given Rx for Pedi-pro & Benadryl.
Information has been received from a nurse practitioner concerning a 36-month-old male who was vaccinated (when he was 1-year-old) with his first 0.5 mL dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). At an unspecified date the patient developed a suspected case of mumps. He is believed to of had exposure to someone who does have mumps. The patient sought unspecified medical attention. A diagnostic lab was performed to check the patient's titer for mumps. At the time of the report the patient's status was not recovered. A product quality complaint was not involved. Additional information has been requested.
My father received his 2nd vaccination in early March 2021.  He reported feeling flu-like afterwards. He ran a fever and developed severe diarrhoea.  Shortly thereafter, he became ill with pneumonia which he suffered on and off with for the next two months.  His condition continued to decline until his eventual death in May 2021.
Almost two weeks to the day I had a severe ear infection in the Left ear (middle ear). Antibiotics required.
I had flu shot on 10-14-2010. First symptoms Nov 1, 2010, difficulty climbing stairs, then rising from seated position, weakness arms, then entire body. Could not walk then could not stand, then choking on saliva & food, then difficulty breathing.
itch; Rash on chest and rest of his body; rash near the shot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itch), RASH (Rash on chest and rest of his body) and RASH (rash near the shot) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itch), RASH (Rash on chest and rest of his body) and RASH (rash near the shot). The patient was treated with TRIAMCINOLONE ACETONIDE at an unspecified dose and frequency. At the time of the report, PRURITUS (itch) had not resolved and RASH (Rash on chest and rest of his body) and RASH (rash near the shot) outcome was unknown.            No relevant concomitant medications were reported.   This case was linked to MOD-2021-071410, US-MODERNATX, INC.-MOD-2021-071410 (E2B Linked Report).; Sender's Comments:  MOD-2021-071410:First dose case US-MODERNATX, INC.-MOD-2021-071410:Second dose case
Pt. received 2nd MMR & VARICELLA to soon. No adverse reaction.
pt recv vax;3rd day of vax,very tired,red area on arm enlarged,hot,firm,itchy;4rth day,swelling,lack of strength in lt arm where inject given; 5th day rxn cont lt arm inject site to elbow
Woke day after injection with dull headache as the day went on by 2pm  I became extremely dizzy. The dizziness continued into the next day and then the third day as well. Woke the fourth day Thursday and dizziness was almost gone gone. By end of day no longer dizzy.
Initial information received on 08-Feb-2019 regarding an unsolicited valid serious case received from a physician. This case involves a patient of unknown age who had passed out, while he/she received vaccines TRUMENBA, INFLUENZA VACCINE (Flu shot) and MENACTRA. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On an unspecified date of Nov-2017, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot number, expiry date, dose, dose in series, route and site of administration was not reported). On an unspecified date of Nov-2017, the patient received a dose of suspect INFLUENZA VACCINE (Flu shot) (lot number, expiry date, dose, dose in series, route and site of administration was not reported). On an unspecified date of Nov-2017, the patient received a dose of suspect TRUMENBA not produced by Sanofi Pasteur (lot number, expiry date, dose, dose in series, route and site of administration was not reported). On an unspecified date of Nov-2017, following the vaccination the patient experienced passed out (loss of consciousness). This event was assessed as medically significant. (Other relevant tests included no lab data.) Final diagnosis was passed out. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for passed out. List of documents held by sender: none.; Sender's Comments: This case concerns a patient of unknown age who presented with loss of consciousness after vaccination with MENACTRA, TRUMENBA and INFLUENZA VACCINE. The time to onset, patient's condition at time of vaccination and lab tests to rule out alternate etiologies are not reported. Based upon the reported information, the role of an individual vaccine cannot be assessed.
This patient received her 2nd COVID vaccine on 1/19 at her place of employment. She had no symptoms for 21 hours. At 4AM on January 20th, this patient awoke with chills and muscle/joint aches. This patient did not take a temperature at the time (knowing these were common symptoms), and instead managed them with Advil and Tylenol. On Friday the 22nd, this patient awoke with worsening chills and sudden nausea. She took her temperature, which was 100.5. This patient called employee health and asked if symptoms lasting  over 48 hours were ordinary or if she should be tested for COVID-19. Employee health informed patient to get tested in case of exposure. Patient was negative, however remained nauseous and had low grade fevers and aches. On the 23rd, patient awoke with severe nausea and vomiting. Patient called her primary care provider for zofran prescription, which was granted.  Zofran was taken around the clock until 1/26. Additionally, patient continued to have chills and aches until 1/25, again managed by alternating Advil and Tylenol.  Also on 1/25, patient noticed flat, erythemic rash covering her abdomen and back. Patient applied hydrocortisone cream and took Benadryl. As of today, 1/27, patient is afebrile, not nauseous, and rash has disappeared.
This spontaneous prospective pregnancy report was received from a Nurse Practitioner refers to a approximately 16 year old female patient. No medical history was reported. On 08-AUG-2011, the patient received dose 1 GARDASIL (lot# 1511Z, expiry: 26-APR-2013) 0.5 ml intramuscularly and dose 2 of GARDASIL(lot# 1561AA, expiry: August 2014) 0.5 ml intramuscularly on 20-APR-2012. On 28-DEC-2012, the patient was vaccinated with dose 3 GARDASIL(Lot #, expiry: March 2015) 0.5 ml, intramuscularly. Concomitant therapies included prenatal vitamins (unspecified) and unspecified antibiotics (ANTIMICROBIAL (UNSPECIFIED)) prescribed for the patient 2 weeks ago. The patient became pregnant with LMP of 28-SEP-2012 and EDD of 05-JUL-2013. The pregnancy outcome was outcome pending. The Nurse Practitioner  reported that the pregnant patient received GARDASIL. Patient sought medical attention(office visit). Additional information has been requested.
pt mom called & c/o on 14OC96 stated pt devel blister which became sore & filled w/pus;seen by MD who stated it was d/t vax;10min sore-hard center noted to rt back area or thigh
Previously healthy 40 y/o female with sulfa allergy and received dose #1 of Moderna COVID-19 vaccine on 1/5/21.  Experienced fatigue, chills, bodyaches on 1/6/21 and resolved by 1/7/21.  Rash below injection site appeared on 1/9/21 that was red, itchy, and inflamed with a palpable lump.  Rash slowly dissipated by 1/15/21.  On 1/16/21, experienced generalized pruritis  and tingling in hands, feet, and legs.  Over the course of the next 3 days, experienced tingling, numbness, burning, and pain in upper and lower extremities that interfered with sleep and daily function and was not resolved with self mediation with acetaminophen and diphenhydramine.  On 1/19/21, primary care provider was contacted.   PCP consulted allergist/immunologist who did not think symptoms were related to an allergic reaction to the vaccine. Referred to neurologist for further workup  and prescribed gapabentin for symptom control.   Neuropathy slowly resolved over the following week by around 1/25/21-1/27/21.
3/17/21 ER Triage note: "Pt c/o lips and and facial swelling. No sob, no problems swallowing. Onset this am. Denies pain."
Acute kidney injury. ED visit and hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
Raised small circular lump at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Raised small circular lump at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Raised small circular lump at injection site). At the time of the report, VACCINATION SITE MASS (Raised small circular lump at injection site) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
This spontaneous report was received from a Nurse Practitioner referring to a 25 year old patient of unknown gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On approximately, an unspecified date in 2008 (reported as "10 years ago") the patient received the first dose in the human papillomavirus (HPV) vaccination series with either GARDASIL 9 or GARDASIL (dose, frequency,  lot#, expiration date were not reported) for prophylaxis, but it was unknown which of both vaccines was administered. On 15-MAY-2018, the patient received the second dose in the HPV vaccination series with GARDASIL 9, dose 0.5 ml, lot # N014464, expiration date on 19-DEC-2019,  intramuscularly for prophylaxis (interchange of vaccine products). No adverse effects were reported.
Intense pain in entire left arm starting about an hour after vaccination on the 12th. Around 11am on the 13th, I began to experience a fever (of 101 degrees), chills, intense body aches, headache, nausea, and fatigue. At night, I had night sweats and could barely sleep. It's now the morning of the 14th and I still have the fever, body aches, and pain in upper right arm. The rest of the symptoms seem to have subsided. For background, I had COVID-19 in March of 2020, so I am wondering if that is why I had such an adverse reaction to this first vaccine dose.
*Very sore at injection site and when I move my right arm *Headache *Exhausted/Wore out feeling *Stomach Ache with Gas
Around 1:00pm  received the Pfizer COVID- 19 vaccine at the group home administered by  staff.  About 10 minutes after getting the vaccine begin to develop an allergic reaction on both arms. The  staff observed for about 15 more minutes and advised if condition worsens to seek medical attention. The group home administrator was contacted.  As a precaution  was taken to . While at the Urgent Care more hives developed on his arms, neck and buttock area. He was evaluated by the doctor and two injections were given. Benadryl 50 mg intramuscular and Solu- Medrol 125mg intramuscular. He was observed by the doctor and nurses for 30 minutes after the injections, the reaction improved.  was prescribed Benadryl 25mg 1 capsule every 12 hours for 5 days and Prednisone 20mg 3 tablets daily for 4 days.  was discharged and is at home in stable condition with close supervision.  will follow up with his Primary Care Physician as scheduled. is doing well. Skin has cleared.
pain and muscle weakness and strain down both my arms and elbows - sporadic body aches and pains all over - pain at injection site, neck, headaches. My muscles also feel very weak. I feel my strength is not the same in my muscles and joints, I seriously sprained my ankle just moving and it just feels like my body is weak and vulnerable since the shot.
full bladder feeling/ feeling a need to urinate; having excessive urination; injection sites felt hard; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (injection sites felt hard), POLLAKIURIA (full bladder feeling/ feeling a need to urinate) and URINE OUTPUT INCREASED (having excessive urination) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug hypersensitivity (sensitive to sodium.) and Immunocompromised.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INDURATION (injection sites felt hard), POLLAKIURIA (full bladder feeling/ feeling a need to urinate) and URINE OUTPUT INCREASED (having excessive urination). At the time of the report, VACCINATION SITE INDURATION (injection sites felt hard), POLLAKIURIA (full bladder feeling/ feeling a need to urinate) and URINE OUTPUT INCREASED (having excessive urination) outcome was unknown.            No concomitant medication was reported.  No treatment medication was reported.   This case was linked to MOD-2021-319270 (Patient Link).
Hospitalized 1/9/2022; COVID-19 positive 01/09/2022; fully vaccinated plus booster  BRIEF OVERVIEW: Discharge Provider:  Primary Care Provider: DO Admission Date: 1/9/2022 Discharge Date: Jan 14, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 59-year-old female with past medical history significant for HTN, DM2, HLD, right cerebral infarct (2017) with left-sided hemiparesis, also multifocal multi vascular territory ischemic strokes,history of left-sided hydronephrosis secondary to compression from an adnexal mass (status post cystoscopy, left ureteral stent placement 11/13/2021), history of left ovarian mass 08/2021 (with plans for surgery on 01/13), presents to the hospital on 1/9 with complaints of malaise, weakness, diarrhea, cough and headache.  She was evaluated in ER and was found to have COVID-19 and was attributed to be the etiology of her diarrhea and malaise.   COVID-19 infection:  Chest x-ray showing atelectasis without infiltrate, patient on room air 100 not need any therapeutics.   Malaise and diarrhea:  This was attributed to COVID-19 infection, was put on Imodium but only needed 1 dose, subsequently was put on fiber as well, diarrhea improved.  PT/OT evaluated her and recommended subacute rehab and was transferred on 01/14.   Enlarging ovarian mass:  Patient was previously scheduled to have intervention done on 01/13 for this known the left adnexal mass however, to hospitalization, this was canceled and needs to be scheduled in the future.  Patient will be needing ureteral stent exchange on 02/13.   Diabetes:  Patient on Ozempic along with Lantus/Humalog at home, but needed significantly lower doses of insulin during the hospital stay.  Discharge instructions reflected this change.   Iron deficiency/anemia:  No bleeding was noted however patient was noted to have iron deficiency and received 2 doses of Venofer while in the hospital.
Where the injection was given is real sore; Chills; Muscle pain; Joint pain; Fever; Nauseated; shaking really hard; feeling unwell; still cold; Just like when one catches the flu, all the symptoms came at one time; It was so stiff one time; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number EK01231), via intramuscular route on the left arm on 19Jan2021 12:11 as a single dose for COVID-19 immunization. Medical history included stomach issues, two stents, pacemaker, asthma that turned into bronchitis. Historical vaccine data included the pneumococcal 13-valent conjugate vaccine (PREVNAR 13) first dose in "September" and the second Pneumonia shot on 11Jan2021, second dose, on the right arm within 4 weeks prior to the COVID vaccine. Concomitant medication included ongoing prasugrel for blood thinner.  On 20Jan2021 03:00, the patient experienced really heavy chills, she was shaking really hard, she had muscle pain like the flu, joint pain, fever that started at 100.6 degrees Fahrenheit and worsened to 101.6 degrees Fahrenheit, nauseated, feeling unwell. The caller clarifies that all of the symptoms came on at once, around 3am. Just like when one catches the flu, all the symptoms came at one time. The patient reported that it felt like she had the virus (not specified) all over again. The chills had calmed down, but she was still cold. Where the injection was given it was real sore. She had been doing arm circles and such to keep her muscles loosened up. It was so stiff at one time last night (20Jan2021) that she thought, she could not move it. The clinical outcome of events chills was recovering; muscle pain, fever, nauseated, still cold was not recovered; joint pain, shaking really hard, feeling unwell, vaccination site pain, stiff, flu like symptoms was unknown.
pc from mom 2PM 5APR95 reporting pt w/crying for 2 hrs w/cyanotic legs 7 stripes acorss the bottoms & tops of feet; red areas on abdo; brought pt by clinic on way to MD ofc; 230PM t100.0R-red across area on abdo;
Neck on left side (where shot was administered) was at least 3x larger than right. Throat was closing slowly. Tongue tingling and numb similar to when I eat eggplant. Feeling of impending doom. Those are the most significant reactions; all on top of severe reactions to the shot itself. I had covid back in March 2019. The allergic reaction started at 7am and continued throughout the night. I spoke with a nurse on the phone and felt slightly better after taking Benadryl.
The patient failed to seroconvert after 2 vaccinations with varicella virus vaccine live. Unspecified medical attention was sought. Additional information has been requested.
The patient was vaccinated 10/30/6.  The following day she presented to employee health witha  3" x 3" reddened hardened area at the site of injection.
Noticed a rash to her left arm (where injection site was) and it spread somewhat along her upper arm. It is raised and white, similar to what psoriasis looks like, but feels bumpy. I noticed also today she keeps falling down a lot more than her usual.  There are no other signs of illness.
Pt presented with increased swelling of (L) deltoid where MENACTRA was given. Prescribed CEPHALEXIN 500 mg 1-TID x 10 day for cellulitis.
Pt. states that after receiving the 1st dose of Moderna 12/03/2021, started experiencing symptoms that evening of chest pains, fluttering sensation, and weakness in the upper body. Emergency Room visit 01/2022, recommendations for Follow-Up with Primary. Pt. still continuing to experience symptoms.
Lip swelling and redness; Lip swelling and redness; This is a spontaneous report from a contactable nurse (patient). A 26-year-old female patient (nor pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration (right arm) on 21Dec2020 (10:45) at single dose for COVID-19 immunization. The patient's medical history included asthma. Concomitant medication included montelukast sodium (SINGULAIR) cetirizine hydrochloride (ZYRTEC) and acetazolamide sodium (DIAMOX), received within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced lip swelling and redness on 24Dec2020 (04:00 AM). The adverse events resulted in Doctor or other healthcare professional office/clinic visit. The patient was advised to continue Singulair and given Benadryl and ointment as treatment for the adverse events. The outcome of events was unknown. The patient has not been tested for COVID-19 since the vaccination. This case is non-serious.  Information about lot/batch number has been requested.
Information has been received from a nurse concerning a 6 year old female with no known allergies and a history of sinus hydronephrosis and pyonephrosis who on 23-AUG-2001 was vaccinated with a first dose of Varivax. On 12-JAN-2007 the patient presented to the doctor's office with chicken pox. She had an itchy vesicular rash on her right abdomen, under the right arm, on the right and left upper thighs and on the right ankle. Some lesions are scabbed. The child was afebrile, not vomiting and had no other symptoms. At the time of this report the patient had not recovered. Unspecified medical attention was sought. Additional information has been requested.
Diagnosed with covid-19; Fatigued; Feverish; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced FATIGUE (Fatigued) and PYREXIA (Feverish). On 15-Jan-2021, the patient experienced COVID-19 (Diagnosed with covid-19) (seriousness criterion medically significant). At the time of the report, COVID-19 (Diagnosed with covid-19), FATIGUE (Fatigued) and PYREXIA (Feverish) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant details were reported by the reporter. Treatment details not reported by the reporter.  Company Comment: Very limited information regarding the events has been provided at this time. No further information is expected. Causality for fatigue and pyrexia is assessed as possibly related and for COVID-19 as not applicable.; Sender's Comments: Very limited information regarding the events has been provided at this time. No further information is expected. Causality for fatigue and pyrexia is assessed as possibly related and for COVID-19 as not applicable.
Temperature of 103 F, nausea, vomiting, diarrhea for 3 days